Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 31.
doi: 10.1038/s41563-025-02391-8. Online ahead of print.

Tumour priming by ultrasound mechanogenetics for CAR T therapy

Affiliations

Tumour priming by ultrasound mechanogenetics for CAR T therapy

Chi Woo Yoon et al. Nat Mater. .

Abstract

Cell-based cancer immunotherapy holds potential as a therapeutic approach, yet its application for solid tumour treatment remains challenging. Here we report a focused-ultrasound-based approach that mechanically induces the localized expression of CD19 antigen within a subpopulation of cells within solid tumours, which function as local 'training centres' to activate chimeric antigen receptor T cells. Activated chimeric antigen receptor T cells attack the whole cancer cell population near the tumour site, thus achieving cancer suppression. The system achieves targeted gene expression by integrating focused-ultrasound-triggered mechanical stimulation and the subsequent calcium response of cancer cells with a doxycycline-gated AND-logic genetic circuit, both of which need to be active for effective induction of CD19 expression. We validate the functionality of the approach in vitro, in organoids and in vivo, achieving direct control of user-designed gene expressions through FUS-mediated mechanical stimulation without the need of any cofactor, demonstrating the approach's potential as a versatile platform for precisely controllable immunotherapy. Overall, our combinatorial approach offers a focused-ultrasound-controlled remote and non-invasive priming of solid tumours for effective and safe chimeric antigen receptor T cell immunotherapy via the induced production of clinically validated antigens.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Yingxiao Wang is scientific cofounder and consultant of Cell E&G Inc. and Acoustic Cell Therapy Inc. These financial interests do not affect the design, conduct or reporting of this research. The other authors declare no competing interests.

References

    1. Shung, K. K. Diagnostic Ultrasound: Imaging and Blood Flow Measurements (Taylor & Francis, 2006).
    1. Liu, L. et al. Engineering sonogenetic EchoBack-CAR T cells. Cell 188, 2621–2636.e20 (2025). - PubMed - DOI
    1. Deckers, R. et al. Image-guided, noninvasive, spatiotemporal control of gene expression. Proc. Natl Acad. Sci. USA 106, 1175–1180 (2009). - PubMed - PMC - DOI
    1. Abedi, M. H., Lee, J., Piraner, D. I. & Shapiro, M. G. Thermal control of engineered T-cells. ACS Synth. Biol. 9, 1941–1950 (2020). - PubMed - DOI
    1. Wu, Y. et al. Control of the activity of CAR-T cells within tumours via focused ultrasound. Nat. Biomed. Eng 5, 1336–1347 (2021). - PubMed - PMC - DOI

Grants and funding

LinkOut - more resources